Emanate (MN8) - ICO Details

MN8 - Emanate ICO details,price, stage, bonus, team.
Emanate (MN8) Initial Coin Offering Logo
HeadlineAudio Exchange Protocol built on EOSIO. Decentralising the music industry
CategoryEvents & Entertainment
Starting date11/12/2018
Ending date03/22/2019
WebsiteView Website
WhitepaperView Whitepaper

Emanate ICO Summary

Emanate is bringing blockchain solution in the Events & Entertainment industry.

Emanate initial coin offering will be held from November 12, 2018. MN8 will be offered to investors until March 22, 2019.

A total of 208,000,000 MN8 will be created and 48,000,000 will be available during the coin offering.
MN8 coin/token sale will be considered successful if their softcap of 5,000,000(USD) is reached. Please keep in mind that the sale could end before March 22, 2019 if the hardcap of 12,000,000(USD) is reached.

During Emanate ICO, investors will be able to buy MN8 at 0.12 USD per Coin/Token.

Get all the details about Emanate below and on Emanate Official ICO website

What is Emanate

The Emanate Audio Exchange Protocol is a
decentralised technology network designed to
facilitate instant value exchange and agreements
between musicians, listeners and other actors in
the music industry in ways never before possible.

MN8 ICO Details

MN8 Tokenomics & ICO Information
USA accepted
Currency AcceptedBTC,ETH
Coin SymbolMN8
Total Coins208,000,000
Coins for Sale48,000,000
Private-Sale/Pre-Mined Coins0
Coins Sold0%
Coin Price0.12 USD
Softcap Reached
Confirmed Exchange
Unsold Coins Goes to Burn

Stage Details

Main sale

Emanate Stage Information & Bonus
Start date11/12/2018
End date03/22/2019
Token for sale48,000,000
Token Price0.12 USD

Team Info

Core Team

Sean Gardner


Advisory Team

Discuss about MN8

Please Login to join the discussion
Notify of
Featured ICOs
There are No Featured ICOs right now
3Commas Square
Recently Viewed ICO

Facebook group ICL
Join our Newsletter


Don't miss out!

Get discounts on ICOs & Blockchain products + Receive the latest News, Updates & PR from ICL.